CONGRESS PHARMA
ActiveSummary
The computed 12-month bankruptcy probability of CONGRESS PHARMA is 3.0% (moderate). The 2025 annual accounts show equity of €10k and a net result of €-301. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 28% of 11322 sector peers (fiscal year 2025). The company has been active since 2020 and the Belgian State Gazette contains no insolvency or warning signals.
Checked score
Score 2025
47
/ 100
Fair
The score weighs solvency, liquidity, profitability and financial development. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability37▼-13
Solvency38▲+6
Growth78=
Track record100
Bankruptcy probability, 12 months
3.0%
Moderate
0%0.5%1.5%4%10%≥ 25%
Credit check for your own amount and term
Signals
Five signals. The signal on the left, the evidence on the right.
+raises risk○neutral
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation dateAge against the risk zone
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 46
Relative position
BE, all sectors
reference
Sector 46
higher
← fewer bankruptcies
more bankruptcies →
raises risk · Annual accounts: weaker financial profile
The latest annual accounts show a weaker profile in solvency, result or liquidity than companies that stay afloat.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
12.6%
Return on assets
-0.4%
Age of the figures
9 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 16-07-2026, 15 days ahead of the deadline.
NBB · 6 filingsDeviation from the deadline
2025
15 d early
2024
33 d late
2023
65 d late
2022
60 d late
2021
37 d late
2020
265 d late
← before the deadline
after the deadline →
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
25-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, micro schema
Turnover
€0
Total assets
€83k▼ 43.5%
2024 · €146k
2020: €21k
2021: €95k
2022: €524k
2023: €124k
2024: €146k
2020 → 2025
Net result
€-301
2024 · €7k
2020: €-139k
2021: €-31k
2022: €171k
2023: €3k
2024: €7k
2020 → 2025
Working capital
€8k▼ 3.6%
2024 · €8k
2020: €-142k
2021: €-173k
2022: €-2k
2023: €837
2024: €8k
2020 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Turnover€0
Equity€-170k-€729€3k▲ 350%€11k▲ 226%€10k▼ 2.8%
Operating result€-31k-€172k€3k▼ 98.0%€8k▲ 122%€3k▼ 64.3%
Net result€-31k-€171k€3k▼ 98.5%€7k▲ 190%€-301
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result falls in 2025; 2025 is 64% below 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €83k
Fixed assets
€2k =
Current assets
€80k ▼ 44.2%
Equity and liabilities €83k
Equity
€10k ▼ 2.8%
Debt
€72k ▼ 46.7%
Debt's share of the balance-sheet total falls from 92.7% to 87.4%. Equity and debt are lower.
Key figures and ratios
Current ratio
1.11▲
2024 · 1.06
Debt to equity
6.94▼
2024 · 12.66
ROE
-2.9%▼
2024 · 69.3%
ROA
-0.4%▼
2024 · 5.1%
Debt ≤ 1 year
€72k▼
2024 · €135k
Income taxes
€3k▲
2024 · €0
Staff costs
€0▲
2024 · €-8k
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2025 against 2024 · 33 lines
Balance sheet
Code20242025
Assets
Total assets20/58€146k€83k▼
Fixed assets21/28€2k€2k=
Financial fixed assets28€2k€2k=
Current assets29/58€144k€80k▼
Amounts receivable within one year40/41€136k€37k▼
Trade receivables40€118k€19k▼
Other amounts receivable41€17k€18k▲
Cash at bank and in hand54/58€8k€43k▲
Equity and liabilities
Total equity and liabilities10/49€146k€83k▼
Equity10/15€11k€10k▼
Contributions10/11€1€1=
Profit (loss) carried forward14€11k€10k▼
Amounts payable17/49€135k€72k▼
Amounts payable within one year42/48€135k€72k▼
Trade debts44€135k€72k▼
Suppliers440/4€135k€72k▼
Taxes, remuneration and social security45€0-
Remuneration and social security454/9€0-
Other amounts payable47/48€0-
Income statement
Code20242025
Remuneration, social security and pensions62€-8k€0▲
Other operating charges640/8€800€9k▲
Gross operating margin9900€452€12k▲
Operating profit (loss)9901€8k€3k▼
Financial income75/76B€0-
Recurring financial income75€0-
Financial charges65/66B€179€231▲
Recurring financial charges65€179€231▲
Profit (loss) for the period before taxes9903€7k€2k▼
Income taxes67/77€0€3k▲
Profit (loss) for the period9904€7k€-301▼
Profit (loss) for the period to be appropriated9905€7k€-301▼
Appropriation of the result
Profit (loss) to be appropriated9906€11k€10k▼
Profit (loss) brought forward from the previous period14P€3k€11k▲
The notes to these accounts (6 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
16-07
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
2025
02-09
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema · 33 days late
2024
04-10
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema · 65 days late
2023
29-09
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema · 60 days late
2022
31-12
Financial
Back to profitnet €171k
Net result €171k after 2 loss-making years.
06-09
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema · 37 days late
22-04
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema · 265 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 2 acts read
About the unread acts
We know of 2 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
2 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Sint-Pieters-Woluwe · 1 establishment unit since 2020
Ground area
7,652 m²
Building footprint
183 m²
Volume, LiDAR
2,191 m³
2 parcels, Brussels, Wallonia · tallest building 17.7 m, ±5 floors. Linked by address, not a title deed.
10
companies at this address
See who is registered here
1 establishment unit
CONGRESS PHARMA
since 20202.304.291.517
2 parcels
Wallonia
1
(50%)
Brussels
1
(50%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 25386B0122/00R004 | Wallonia | 7,285 m² | 1 · 26 m² | 6.0 m · 2 fl. |
| 21019A0193/00E002 | Brussels | 367 m² | 1 · 157 m² | 17.6 m · 5 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1 · via establishment units: 1
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
LINDEN API
BE 1013.228.346
Elsene · Eq €10,377
HONEYPATCH
BE 0524.896.791
Liège · Eq €10,057
MED INSPIRE
BE 0657.885.672
Brussel · Eq €10,864
VITAAL
BE 0686.750.102
Schoten · Eq €10,902
MEDESTIME
BE 0445.829.321
Charleroi · Eq €11,056
Of 1,897 companies in sector 46460 we hold annual accounts for 1,116. 231 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded17-02-2020
Fiscal year end31-12
Activities, NACEBEL 2025
46460Wholesale of pharmaceutical and medical goods
72109Other research and development on natural sciences
Sources
Crossroads Bank for EnterprisesNational Bank · 6 filingsAddress and cadastre registers
Scores and ratios are computed by Checked and are not a credit decision.
Contact details
2 entriesE-mail:rbaucy@besins-healthcare.com
Phone:0479994933